Skip to Content

North China Pharmaceutical Huasheng CO, China, 2023

GMP Audit Report

Company
North China Pharmaceutical Huasheng CO

Product(s)
Dihydrostreptomycin Sulfate Injection

Country
China

Audit Year
2023

0.00 € 0.00 €
0.00 €